Company profile for Cyclotek

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cyclotek is a leading Contract Development and Manufacturing Organization (CDMO) specializing in radiopharmaceuticals. Established in 2001, the company operates a network of GMP-certified facilities across Australia and New Zealand, providing reliable, cost-effective, and innovative Positron Emission Tomography (PET) radiopharmaceuticals for clinical diagnostics and research. Cyclotek offers a full suite of services, including...
Cyclotek is a leading Contract Development and Manufacturing Organization (CDMO) specializing in radiopharmaceuticals. Established in 2001, the company operates a network of GMP-certified facilities across Australia and New Zealand, providing reliable, cost-effective, and innovative Positron Emission Tomography (PET) radiopharmaceuticals for clinical diagnostics and research. Cyclotek offers a full suite of services, including radiolabeling, quality control, and logistics, supporting both routine clinical use and early-phase clinical trials.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
38 Clements Avenue, Bundoora, Victoria. 3083
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/06/24/3104176/0/en/Radiopharm-Theranostics-and-Cyclotek-Sign-Clinical-Supply-Agreement-for-Tb-KLK3-mAb-Phase-I-Clinical-Trial-in-Australia.html

GLOBENEWSWIRE
24 Jun 2025

https://www.prnewswire.com/news-releases/imaginab-and-cyclotek-enter-into-manufacturing-and-distribution-agreement-for-cd8-immunopet-agent-in-australia-301649932.html

PRNEWSWIRE
17 Oct 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty